Latuda vs Saphris

Latuda
Saphris
Other name: lurasidone lurasidone
Other name: Asenapine Asenapine
Satisfaction Score
?
2.8
Moderately Satisfied
Satisfaction Score
?
2.8
Moderately Satisfied
Helpfulness
for Depression
4.6
Concern level
3.7
Helpfulness
for Depression
4.7
Concern level
3.6
19,276
Discussions around the web
Discussions
12,735
Discussions around the web
Discussions
Taken for:
by discussions around the web
Depression
Bipolar Disorder
Psychosis
Schizophrenia
Taken for:
by discussions around the web
Depression
Bipolar Disorder
Psychosis
Schizophrenia
Method of use:
Pill
Method of use:
Pill
Prescribing mode:
Rx
Prescribing mode:
Rx
Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval ...
Read on Wikipedia
Asenapine (International Nonproprietary Name, trade names Saphris, Sycrest) is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19...
Read on Wikipedia
Top Concerns
Lat
Weight Gain
8
Tiredness
3
Insomnia
3
Weight Loss
2
Nausea
2
Withdrawal Symptoms
1
Irritability
1
Hallucinations
1
Drowsiness
1
Suicidal behavior
1
Top Concerns
Sap
Weight Gain
10
Tiredness
3
Weight Loss
2
Numbness
1
Suicidal behavior
1
Diabetes
1
RLS
1
Hangover
1
Nightmares
1
Delusions
1
Compare concerns
By:
Latuda
Lat
Saphris
Sap
Weight Gain
Lat
Sap
8
10
Tiredness
Lat
Sap
3
3
Insomnia
Lat
Sap
3
0
Weight Loss
Lat
Sap
2
2
Nausea
Lat
Sap
2
0
Withdrawal Symptoms
Lat
Sap
1
0
Irritability
Lat
Sap
1
0
Hallucinations
Lat
Sap
1
0
Drowsiness
Lat
Sap
1
0
Suicidal behavior
Lat
Sap
1
1
Weight Gain
Sap
Lat
10
8
Tiredness
Sap
Lat
3
3
Weight Loss
Sap
Lat
2
2
Numbness
Sap
Lat
1
0
Suicidal behavior
Sap
Lat
1
1
Diabetes
Sap
Lat
1
0
RLS
Sap
Lat
1
0
Hangover
Sap
Lat
1
0
Nightmares
Sap
Lat
1
0
Delusions
Sap
Lat
1
0
Back
About Latuda
Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval ...
Read on Wikipedia
Read more about:
Latuda
About Saphris
Asenapine (International Nonproprietary Name, trade names Saphris, Sycrest) is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19...
Read on Wikipedia
Read more about:
Saphris
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 1,569 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Treato does not provide medical advice, diagnoses or treatment. Services are ranked based on reviews gathered from around the web and may refer to different aspects of each service (Price, waiting time, general satisfaction, etc.) Treato does not guarantee any specific rate or promotion. In addition, prices for some services provided by the listed Telehealth companies may vary, please check with the Telehealth site for the exact price for the desired service. Treato is not responsible for promotions validity, application of the promotion code varies among the different Telehealth sites (for example during registration flow). It is your responsibility to apply the promotion code. Treato is not responsible for content on external web sites.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Back to Signup
Please wait...